| 1. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
| 2. Wiesner J, Mitsch A, Wissner P, Jomaa H, Schlitzer M.. (2001) Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives., 11 (3): [PMID:11212126] [10.1016/s0960-894x(00)00684-3] |
| 3. Alzeer J, Chollet J, Heinze-Krauss I, Hubschwerlen C, Matile H, Ridley RG.. (2000) Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore., 43 (4): [PMID:10691682] [10.1021/jm990002y] |
| 4. Nebois P, Sarciron ME, Bibal B, Bouammali B, Cherkaoui O, Pautet F, Pétavy AF, Walchshofer N, Fillion H.. (2000) Quinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquinolinetriones., 10 (9): [PMID:10853649] [10.1016/s0960-894x(00)00112-8] |
| 5. Ling Y, Sahota G, Odeh S, Chan JM, Araujo FG, Moreno SN, Oldfield E.. (2005) Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations., 48 (9): [PMID:15857119] [10.1021/jm040132t] |
| 6. Baniecki ML, Wirth DF, Clardy J.. (2007) High-throughput Plasmodium falciparum growth assay for malaria drug discovery., 51 (2): [PMID:17116676] [10.1128/aac.01144-06] |
| 7. Benoit-Vical F, Lelièvre J, Berry A, Deymier C, Dechy-Cabaret O, Cazelles J, Loup C, Robert A, Magnaval JF, Meunier B.. (2007) Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes., 51 (4): [PMID:17242150] [10.1128/aac.00967-06] |
| 8. Saleh A, Friesen J, Baumeister S, Gross U, Bohne W.. (2007) Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenases., 51 (4): [PMID:17242151] [10.1128/aac.00895-06] |
| 9. Liñares GG, Gismondi S, Codesido NO, Moreno SN, Docampo R, Rodriguez JB.. (2007) Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation., 17 (18): [PMID:17643987] [10.1016/j.bmcl.2007.07.012] |
| 10. Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060] |
| 11. Kaiser M, Wittlin S, Nehrbass-Stuedli A, Dong Y, Wang X, Hemphill A, Matile H, Brun R, Vennerstrom JL.. (2007) Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160)., 51 (8): [PMID:17562801] [10.1128/aac.00225-07] |
| 12. Dong CK, Patel V, Yang JC, Dvorin JD, Duraisingh MT, Clardy J, Wirth DF.. (2009) Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors., 19 (3): [PMID:19097788] [10.1016/j.bmcl.2008.11.071] |
| 13. Gochfeld DJ, Hamann MT.. (2001) Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp., 64 (11): [PMID:11720540] [10.1021/np010216u] |
| 14. Yeates CL, Batchelor JF, Capon EC, Cheesman NJ, Fry M, Hudson AT, Pudney M, Trimming H, Woolven J, Bueno JM, Chicharro J, Fernández E, Fiandor JM, Gargallo-Viola D, Gómez de las Heras F, Herreros E, León ML.. (2008) Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials., 51 (9): [PMID:18396855] [10.1021/jm0705760] |
| 15. Rodrigues T, Guedes RC, dos Santos DJ, Carrasco M, Gut J, Rosenthal PJ, Moreira R, Lopes F.. (2009) Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials., 19 (13): [PMID:19467600] [10.1016/j.bmcl.2009.05.017] |
| 16. Wright AD, Lang-Unnasch N.. (2009) Diterpene formamides from the tropical marine sponge Cymbastela hooperi and their antimalarial activity in vitro., 72 (3): [PMID:19199790] [10.1021/np800654w] |
| 17. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
| 18. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.. (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination., 53 (3): [PMID:20070106] [10.1021/jm901371v] |
| 19. El Hage S, Ane M, Stigliani JL, Marjorie M, Vial H, Baziard-Mouysset G, Payard M.. (2009) Synthesis and antimalarial activity of new atovaquone derivatives., 44 (11): [PMID:19747753] [10.1016/j.ejmech.2009.07.021] |
| 20. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
| 21. Bajohr LL, Ma L, Platte C, Liesenfeld O, Tietze LF, Gross U, Bohne W.. (2010) In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii., 54 (1): [PMID:19884369] [10.1128/aac.01001-09] |
| 22. Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT.. (2010) Spiroindolones, a potent compound class for the treatment of malaria., 329 (5996): [PMID:20813948] [10.1126/science.1193225] |
| 23. Mahmoudi N, Garcia-Domenech R, Galvez J, Farhati K, Franetich JF, Sauerwein R, Hannoun L, Derouin F, Danis M, Mazier D.. (2008) New active drugs against liver stages of Plasmodium predicted by molecular topology., 52 (4): [PMID:18212104] [10.1128/aac.01043-07] |
| 24. Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, Garin JF, Derouin F.. (2008) In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone., 52 (4): [PMID:18212105] [10.1128/aac.01203-07] |
| 25. Cross RM, Monastyrskyi A, Mutka TS, Burrows JN, Kyle DE, Manetsch R.. (2010) Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity., 53 (19): [PMID:20828199] [10.1021/jm1007903] |
| 26. Tasdemir D, Sanabria D, Lauinger IL, Tarun A, Herman R, Perozzo R, Zloh M, Kappe SH, Brun R, Carballeira NM.. (2010) 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections., 18 (21): [PMID:20855214] [10.1016/j.bmc.2010.08.055] |
| 27. Savini H, Bogreau H, Bertaux L, Bouchiba H, Kraemer P, Parzy D, Garnotel E, Rogier C, Simon F, Pradines B.. (2008) First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros., 52 (6): [PMID:18411319] [10.1128/aac.00282-08] |
| 28. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 29. Parquet V, Briolant S, Torrentino-Madamet M, Henry M, Almeras L, Amalvict R, Baret E, Fusaï T, Rogier C, Pradines B.. (2009) Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria., 53 (6): [PMID:19307369] [10.1128/aac.01462-08] |
| 30. Lucumi E, Darling C, Jo H, Napper AD, Chandramohanadas R, Fisher N, Shone AE, Jing H, Ward SA, Biagini GA, DeGrado WF, Diamond SL, Greenbaum DC.. (2010) Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay., 54 (9): [PMID:20547797] [10.1128/aac.00431-10] |
| 31. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF.. (2004) Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling., 1 (4): [PMID:16472241] [10.2174/1570163043334794] |
| 32. Unpublished dataset, |
| 33. Zhou J, Duan L, Chen H, Ren X, Zhang Z, Zhou F, Liu J, Pei D, Ding K, Ding K.. (2009) Atovaquone derivatives as potent cytotoxic and apoptosis inducing agents., 19 (17): [PMID:19632833] [10.1016/j.bmcl.2009.07.044] |
| 34. Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, Floyd DM, Matthews D, Buckner FS, Charman SA, Phillips MA, Rathod PK.. (2011) Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice., 54 (11): [PMID:21517059] [10.1021/jm200265b] |
| 35. Cross RM, Maignan JR, Mutka TS, Luong L, Sargent J, Kyle DE, Manetsch R.. (2011) Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships., 54 (13): [PMID:21630666] [10.1021/jm200015a] |
| 36. Gordey EE, Yadav PN, Merrin MP, Davies J, Ward SA, Woodman GM, Sadowy AL, Smith TG, Gossage RA.. (2011) Synthesis and biological activities of 4-N-(anilinyl-n-[oxazolyl])-7-chloroquinolines (n=3' or 4') against Plasmodium falciparum in in vitro models., 21 (15): [PMID:21723121] [10.1016/j.bmcl.2011.05.131] |
| 37. Kiang TK, Ensom MH, Chang TK.. (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions., 106 (1): [PMID:15781124] [10.1016/j.pharmthera.2004.10.013] |
| 38. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 39. Cross RM, Namelikonda NK, Mutka TS, Luong L, Kyle DE, Manetsch R.. (2011) Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones., 54 (24): [PMID:22111907] [10.1021/jm200718m] |
| 40. Zhang YK, Plattner JJ, Freund YR, Easom EE, Zhou Y, Ye L, Zhou H, Waterson D, Gamo FJ, Sanz LM, Ge M, Li Z, Li L, Wang H, Cui H.. (2012) Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles., 22 (3): [PMID:22243961] [10.1016/j.bmcl.2011.12.096] |
| 41. Long TE, Lu X, Galizzi M, Docampo R, Gut J, Rosenthal PJ.. (2012) Phosphonium lipocations as antiparasitic agents., 22 (8): [PMID:22414614] [10.1016/j.bmcl.2012.02.045] |
| 42. Pidathala C, Amewu R, Pacorel B, Nixon GL, Gibbons P, Hong WD, Leung SC, Berry NG, Sharma R, Stocks PA, Srivastava A, Shone AE, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Hill A, Fisher NE, Warman AJ, Biagini GA, Ward SA, O'Neill PM.. (2012) Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)., 55 (5): [PMID:22364416] [10.1021/jm201179h] |
| 43. Leung SC, Gibbons P, Amewu R, Nixon GL, Pidathala C, Hong WD, Pacorel B, Berry NG, Sharma R, Stocks PA, Srivastava A, Shone AE, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Hill A, Fisher NE, Warman AJ, Biagini GA, Ward SA, O'Neill PM.. (2012) Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)., 55 (5): [PMID:22364417] [10.1021/jm201184h] |
| 44. Rodrigues T, Prudêncio M, Moreira R, Mota MM, Lopes F.. (2012) Targeting the liver stage of malaria parasites: a yet unmet goal., 55 (3): [PMID:22122518] [10.1021/jm201095h] |
| 45. Derbyshire ER, Prudêncio M, Mota MM, Clardy J.. (2012) Liver-stage malaria parasites vulnerable to diverse chemical scaffolds., 109 (22): [PMID:22586124] [10.1073/pnas.1118370109] |
| 46. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 47. Vicky Avery (a), Jonathan Baell (b), Sanjay Batra (c), Jeremy Burrows (d), Soumya Bhattacharyya (c), Felix Calderon (e), Sue Charman(b), James R. Cronshaw (g), Sergio Wittlin (f), Matin Dean (g), Sandra Duffy (a), Sabine Fletcher (a), Javier Gamo (e), Zoe Hungerford (g), James Pham (h), Stuart Ralph (h), Murray N. Robertson (g), Matthew Tarnowski (g), Matthew H. Todd (g), Alice E. Williamson (g), Paul Willis (d), Karen White (b), Laura White (g), Paul M.Ylioja (g).
(a) Discovery Biology, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, QLD 4111, Australia;
(b) Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia;
(c) Medicinal Chemistry Division, Central Drug Research Institute, PO Box 173, Lucknow, 226 001, India;
(d) Medicines for Malaria Venture, PO Box 1826, 20 rte de Pré-Bois, 1215 Geneva 15, Switzerland;
(e) Tres Cantos Medicines Development Campus, Diseases of the Developing World (DDW), GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Spain;
(f) Swiss Tropical and Public Health Institute, Socinstr. 57, 4051 Basel, Switzerland;
(g) School of Chemistry, The University of Sydney, NSW 2006, Australia;
(h) Department of Biochemistry & Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia.. Open Source Malaria Deposition 1. http://malaria.ourexperiment.org, [10.6019/CHEMBL2113921] |
| 48. Zhang Y, Clark JA, Connelly MC, Zhu F, Min J, Guiguemde WA, Pradhan A, Iyer L, Furimsky A, Gow J, Parman T, El Mazouni F, Phillips MA, Kyle DE, Mirsalis J, Guy RK.. (2012) Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials., 55 (9): [PMID:22435599] [10.1021/jm201642z] |
| 49. Lu X, Altharawi A, Gut J, Rosenthal PJ, Long TE.. (2012) 1,4-naphthoquinone cations as antiplasmodial agents: hydroxy-, acyloxy-, and alkoxy-substituted analogues., 3 (12): [PMID:24936235] [10.1021/ml300242v] |
| 50. Sharma A, Santos IO, Gaur P, Ferreira VF, Garcia CR, da Rocha DR.. (2013) Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl[1,4]naphthoquinones and their activity against the human malaria parasite Plasmodium falciparum (3D7)., 59 [PMID:23202850] [10.1016/j.ejmech.2012.10.052] |
| 51. Munier-Lehmann H, Vidalain PO, Tangy F, Janin YL.. (2013) On dihydroorotate dehydrogenases and their inhibitors and uses., 56 (8): [PMID:23452331] [10.1021/jm301848w] |
| 52. Rodrigues T, da Cruz FP, Lafuente-Monasterio MJ, Gonçalves D, Ressurreição AS, Sitoe AR, Bronze MR, Gut J, Schneider G, Mota MM, Rosenthal PJ, Prudêncio M, Gamo FJ, Lopes F, Moreira R.. (2013) Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria., 56 (11): [PMID:23701465] [10.1021/jm400246e] |
| 53. Flannery EL, Fidock DA, Winzeler EA.. (2013) Using genetic methods to define the targets of compounds with antimalarial activity., 56 (20): [PMID:23927658] [10.1021/jm400325j] |
| 54. Elicio PD, Chao MN, Galizzi M, Li C, Szajnman SH, Docampo R, Moreno SN, Rodriguez JB.. (2013) Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents., 69 [PMID:24090919] [10.1016/j.ejmech.2013.09.009] |
| 55. Castera-Ducros C, Paloque L, Verhaeghe P, Casanova M, Cantelli C, Hutter S, Tanguy F, Laget M, Remusat V, Cohen A, Crozet MD, Rathelot P, Azas N, Vanelle P.. (2013) Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series., 21 (22): [PMID:24080103] [10.1016/j.bmc.2013.09.002] |
| 56. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
| 57. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 58. PubChem BioAssay data set, |
| 59. PubChem BioAssay data set, |
| 60. Dubar F, Wintjens R, Martins-Duarte ES, Vommaro RC, de Souza W, Dive D, Pierrot C, Pradines B, Wohlkonig A, Khalife J, Biot C. (2011) Ester prodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies, 2 (5): [10.1039/C1MD00022E] |
| 61. Cowley R, Leung S, Fisher N, Al-Helal M, Berry NG, Lawrenson AS, Sharma R, Shone AE, Ward SA, Biagini GA, ONeill PM. (2012) The development of quinoloneesters as novel antimalarial agents targeting the Plasmodium falciparum bc1protein complex, 3 (1): [10.1039/C1MD00183C] |
| 62. Rackham MD, Brannigan JA, Rangachari K, Meister S, Wilkinson AJ, Holder AA, Leatherbarrow RJ, Tate EW.. (2014) Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP)., 57 (6): [PMID:24641010] [10.1021/jm500066b] |
| 63. Nilsen A, Miley GP, Forquer IP, Mather MW, Katneni K, Li Y, Pou S, Pershing AM, Stickles AM, Ryan E, Kelly JX, Doggett JS, White KL, Hinrichs DJ, Winter RW, Charman SA, Zakharov LN, Bathurst I, Burrows JN, Vaidya AB, Riscoe MK.. (2014) Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers., 57 (9): [PMID:24720377] [10.1021/jm500147k] |
| 64. Oliveira R, Guedes RC, Meireles P, Albuquerque IS, Gonçalves LM, Pires E, Bronze MR, Gut J, Rosenthal PJ, Prudêncio M, Moreira R, O'Neill PM, Lopes F.. (2014) Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials., 57 (11): [PMID:24824551] [10.1021/jm5004528] |
| 65. Hansen FK, Sumanadasa SD, Stenzel K, Duffy S, Meister S, Marek L, Schmetter R, Kuna K, Hamacher A, Mordmüller B, Kassack MU, Winzeler EA, Avery VM, Andrews KT, Kurz T.. (2014) Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages., 82 [PMID:24904967] [10.1016/j.ejmech.2014.05.050] |
| 66. Hameed P S, Chinnapattu M, Shanbag G, Manjrekar P, Koushik K, Raichurkar A, Patil V, Jatheendranath S, Rudrapatna SS, Barde SP, Rautela N, Awasthy D, Morayya S, Narayan C, Kavanagh S, Saralaya R, Bharath S, Viswanath P, Mukherjee K, Bandodkar B, Srivastava A, Panduga V, Reddy J, Prabhakar KR, Sinha A, Jiménez-Díaz MB, Martínez MS, Angulo-Barturen I, Ferrer S, Sanz LM, Gamo FJ, Duffy S, Avery VM, Magistrado PA, Lukens AK, Wirth DF, Waterson D, Balasubramanian V, Iyer PS, Narayanan S, Hosagrahara V, Sambandamurthy VK, Ramachandran S.. (2014) Aminoazabenzimidazoles, a novel class of orally active antimalarial agents., 57 (13): [PMID:24914738] [10.1021/jm500535j] |
| 67. Ramachandran S, Hameed P S, Srivastava A, Shanbhag G, Morayya S, Rautela N, Awasthy D, Kavanagh S, Bharath S, Reddy J, Panduga V, Prabhakar KR, Saralaya R, Nanduri R, Raichurkar A, Menasinakai S, Achar V, Jiménez-Díaz MB, Martínez MS, Angulo-Barturen I, Ferrer S, Sanz LM, Gamo FJ, Duffy S, Avery VM, Waterson D, Lee MC, Coburn-Flynn O, Fidock DA, Iyer PS, Narayanan S, Hosagrahara V, Sambandamurthy VK.. (2014) N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds., 57 (15): [PMID:25007124] [10.1021/jm500715u] |
| 68. Cross RM, Flanigan DL, Monastyrskyi A, LaCrue AN, Sáenz FE, Maignan JR, Mutka TS, White KL, Shackleford DM, Bathurst I, Fronczek FR, Wojtas L, Guida WC, Charman SA, Burrows JN, Kyle DE, Manetsch R.. (2014) Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium., 57 (21): [PMID:25148516] [10.1021/jm500942v] |
| 69. Chinnapattu M, Sathiyanarayanan KI, Iyer PS.. (2015) Synthesis and biological evaluation of adamantane-based aminophenols as a novel class of antiplasmodial agents., 25 (4): [PMID:25599834] [10.1016/j.bmcl.2014.12.037] |
| 70. Kannan M, Raichurkar AV, Khan FR, Iyer PS.. (2015) Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents., 25 (5): [PMID:25650255] [10.1016/j.bmcl.2015.01.003] |
| 71. Cohen A, Suzanne P, Lancelot JC, Verhaeghe P, Lesnard A, Basmaciyan L, Hutter S, Laget M, Dumètre A, Paloque L, Deharo E, Crozet MD, Rathelot P, Dallemagne P, Lorthiois A, Sibley CH, Vanelle P, Valentin A, Mazier D, Rault S, Azas N.. (2015) Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium., 95 [PMID:25791675] [10.1016/j.ejmech.2015.03.011] |
| 72. Huta BP, Roberts AM, Waters ES, Yu VY, Doyle RP, Mehlenbacher MR, Bou-Abdallah F. (2014) The antimalarial drug atovaquone binds to saposin B with comparable affinity to coenzyme Q10, 5 (6): [10.1039/C3MD00373F] |
| 73. Zhang YK, Plattner JJ, Easom EE, Jacobs RT, Guo D, Sanders V, Freund YR, Campo B, Rosenthal PJ, Bu W, Gamo FJ, Sanz LM, Ge M, Li L, Ding J, Yang Y.. (2015) Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles., 58 (13): [PMID:26067904] [10.1021/acs.jmedchem.5b00678] |
| 74. McConville M, Fernández J, Angulo-Barturen Í, Bahamontes-Rosa N, Ballell-Pages L, Castañeda P, de Cózar C, Crespo B, Guijarro L, Jiménez-Díaz MB, Martínez-Martínez MS, de Mercado J, Santos-Villarejo Á, Sanz LM, Frigerio M, Washbourn G, Ward SA, Nixon GL, Biagini GA, Berry NG, Blackman MJ, Calderón F, O'Neill PM.. (2015) Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials., 58 (16): [PMID:26222445] [10.1021/acs.jmedchem.5b00434] |
| 75. Kaur H, Machado M, de Kock C, Smith P, Chibale K, Prudêncio M, Singh K.. (2015) Primaquine-pyrimidine hybrids: synthesis and dual-stage antiplasmodial activity., 101 [PMID:26142491] [10.1016/j.ejmech.2015.06.045] |
| 76. Santos SA, Lukens AK, Coelho L, Nogueira F, Wirth DF, Mazitschek R, Moreira R, Paulo A.. (2015) Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype., 102 [PMID:26295174] [10.1016/j.ejmech.2015.07.047] |
| 77. Charoensutthivarakul S, David Hong W, Leung SC, Gibbons PD, Bedingfield PTP, Nixon GL, Lawrenson AS, Berry NG, Ward SA, Biagini GA, O'Neill PM. (2015) 2-Pyridylquinoloneantimalarials with improved antimalarial activity and physicochemical properties, 6 (7): [10.1039/C5MD00062A] |
| 78. Terzić N, Konstantinović J, Tot M, Burojević J, Djurković-Djaković O, Srbljanović J, Štajner T, Verbić T, Zlatović M, Machado M, Albuquerque IS, Prudêncio M, Sciotti RJ, Pecic S, D'Alessandro S, Taramelli D, Šolaja BA.. (2016) Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?, 59 (1): [PMID:26640981] [10.1021/acs.jmedchem.5b01374] |
| 79. WHO Anatomical Therapeutic Chemical Classification, |
| 80. British National Formulary (72nd edition), |
| 81. Desroches J, Kieffer C, Primas N, Hutter S, Gellis A, El-Kashef H, Rathelot P, Verhaeghe P, Azas N, Vanelle P.. (2017) Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold., 125 [PMID:27654395] [10.1016/j.ejmech.2016.09.029] |
| 82. Singh K, Okombo J, Brunschwig C, Ndubi F, Barnard L, Wilkinson C, Njogu PM, Njoroge M, Laing L, Machado M, Prudêncio M, Reader J, Botha M, Nondaba S, Birkholtz LM, Lauterbach S, Churchyard A, Coetzer TL, Burrows JN, Yeates C, Denti P, Wiesner L, Egan TJ, Wittlin S, Chibale K.. (2017) Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model., 60 (4): [PMID:28094524] [10.1021/acs.jmedchem.6b01641] |
| 83. Krake SH, Martinez PDG, McLaren J, Ryan E, Chen G, White K, Charman SA, Campbell S, Willis P, Dias LC.. (2017) Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans., 126 [PMID:28002775] [10.1016/j.ejmech.2016.12.024] |
| 84. Leven M, Knaab TC, Held J, Duffy S, Meister S, Fischli C, Meitzner D, Lehmann U, Lungerich B, Kuna K, Stahlke P, Delves MJ, Buchholz M, Winzeler EA, Avery VM, Mordmüller B, Wittlin S, Kurz T.. (2017) 3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally., 60 (14): [PMID:28653845] [10.1021/acs.jmedchem.7b00140] |
| 85. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 86. Zhang YK, Plattner JJ, Easom EE, Jacobs RT, Guo D, Freund YR, Berry P, Ciaravino V, Erve JCL, Rosenthal PJ, Campo B, Gamo FJ, Sanz LM, Cao J.. (2017) Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate., 60 (13): [PMID:28635296] [10.1021/acs.jmedchem.7b00621] |
| 87. Neelarapu R, Maignan JR, Lichorowic CL, Monastyrskyi A, Mutka TS, LaCrue AN, Blake LD, Casandra D, Mashkouri S, Burrows JN, Willis PA, Kyle DE, Manetsch R.. (2018) Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies., 61 (4): [PMID:29215279] [10.1021/acs.jmedchem.7b00738] |
| 88. Aguiar ACC, Panciera M, Simão Dos Santos EF, Singh MK, Garcia ML, de Souza GE, Nakabashi M, Costa JL, Garcia CRS, Oliva G, Correia CRD, Guido RVC.. (2018) Discovery of Marinoquinolines as Potent and Fast-Acting Plasmodium falciparum Inhibitors with in Vivo Activity., 61 (13): [PMID:29879353] [10.1021/acs.jmedchem.8b00143] |
| 89. Brown CE, Kong T, Bordón C, Yolken R, Jones-Brando L, McNulty J.. (2018) One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii., 28 (9): [PMID:29598911] [10.1016/j.bmcl.2018.03.036] |
| 90. Brandão GC, Rocha Missias FC, Arantes LM, Soares LF, Roy KK, Doerksen RJ, Braga de Oliveira A, Pereira GR.. (2018) Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds., 145 [PMID:29324340] [10.1016/j.ejmech.2017.12.051] |
| 91. Dallaston MA, Rajan S, Chekaiban J, Wibowo M, Cross M, Coster MJ, Davis RA, Hofmann A.. (2017) Dichloro-naphthoquinone as a non-classical inhibitor of the mycobacterial carbonic anhydrase Rv3588c., 8 (6): [PMID:30108843] [10.1039/C7MD00090A] |
| 92. Diedrich D, Stenzel K, Hesping E, Antonova-Koch Y, Gebru T, Duffy S, Fisher G, Schöler A, Meister S, Kurz T, Avery VM, Winzeler EA, Held J, Andrews KT, Hansen FK.. (2018) One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites., 158 [PMID:30245402] [10.1016/j.ejmech.2018.09.018] |
| 93. Unpublished dataset, |
| 94. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 95. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 96. David Hong W, Leung SC, Amporndanai K, Davies J, Priestley RS, Nixon GL, Berry NG, Samar Hasnain S, Antonyuk S, Ward SA, Biagini GA, O'Neill PM.. (2018) Potent Antimalarial 2-Pyrazolyl Quinolone bc 1 (Qi) Inhibitors with Improved Drug-like Properties., 9 (12): [PMID:30613327] [10.1021/acsmedchemlett.8b00371] |
| 97. Ahenkorah S, Coertzen D, Tong JX, Fridianto K, Wittlin S, Birkholtz LM, Tan KSW, Lam Y, Go ML, Haynes RK.. (2020) Antimalarial N 1,N 3-Dialkyldioxonaphthoimidazoliums: Synthesis, Biological Activity, and Structure-activity Relationships., 11 (1): [PMID:31938463] [10.1021/acsmedchemlett.9b00457] |
| 98. Singh L, Fontinha D, Francisco D, Mendes AM, Prudêncio M, Singh K.. (2020) Molecular Design and Synthesis of Ivermectin Hybrids Targeting Hepatic and Erythrocytic Stages of Plasmodium Parasites., 63 (4): [PMID:32011136] [10.1021/acs.jmedchem.0c00033] |
| 99. Fersing C, Basmaciyan L, Boudot C, Pedron J, Hutter S, Cohen A, Castera-Ducros C, Primas N, Laget M, Casanova M, Bourgeade-Delmas S, Piednoel M, Sournia-Saquet A, Belle Mbou V, Courtioux B, Boutet-Robinet É, Since M, Milne R, Wyllie S, Fairlamb AH, Valentin A, Rathelot P, Verhaeghe P, Vanelle P, Azas N.. (2019) Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity., 10 (1): [PMID:30655943] [10.1021/acsmedchemlett.8b00347] |
| 100. Fagundez C, Sellanes D, Peña S, Scarone L, Aguiar ACC, de Souza JO, Guido RVC, Stewart L, Yardley V, Ottilie S, Winzeler EA, Gamo FJ, Sanz LM, Serra GL.. (2019) Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing N-Methyl Amino Acids as Antiplasmodial Agents., 10 (1): [PMID:30655961] [10.1021/acsmedchemlett.8b00543] |
| 101. Calil FA, David JS, Chiappetta ERC, Fumagalli F, Mello RB, Leite FHA, Castilho MS, Emery FS, Nonato MC.. (2019) Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase., 167 [PMID:30776695] [10.1016/j.ejmech.2019.02.018] |
| 102. Dodean RA, Kancharla P, Li Y, Melendez V, Read L, Bane CE, Vesely B, Kreishman-Deitrick M, Black C, Li Q, Sciotti RJ, Olmeda R, Luong TL, Gaona H, Potter B, Sousa J, Marcsisin S, Caridha D, Xie L, Vuong C, Zeng Q, Zhang J, Zhang P, Lin H, Butler K, Roncal N, Gaynor-Ohnstad L, Leed SE, Nolan C, Huezo SJ, Rasmussen SA, Stephens MT, Tan JC, Cooper RA, Smilkstein MJ, Pou S, Winter RW, Riscoe MK, Kelly JX.. (2019) Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials., 62 (7): [PMID:30852885] [10.1021/acs.jmedchem.8b01961] |
| 103. Boschi D, Pippione AC, Sainas S, Lolli ML.. (2019) Dihydroorotate dehydrogenase inhibitors in anti-infective drug research., 183 [PMID:31557612] [10.1016/j.ejmech.2019.111681] |
| 104. Fernández-Álvaro E, Hong WD, Nixon GL, O'Neill PM, Calderón F.. (2016) Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of Action., 59 (12): [PMID:26791529] [10.1021/acs.jmedchem.5b01485] |
| 105. Maignan JR, Lichorowic CL, Giarrusso J, Blake LD, Casandra D, Mutka TS, LaCrue AN, Burrows JN, Willis PA, Kyle DE, Manetsch R.. (2016) ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity., 59 (14): [PMID:27291102] [10.1021/acs.jmedchem.6b00759] |
| 106. Ghavami M, Dapper CH, Dalal S, Holzschneider K, Klemba M, Carlier PR.. (2016) Parallel inhibition of amino acid efflux and growth of erythrocytic Plasmodium falciparum by mefloquine and non-piperidine analogs: Implication for the mechanism of antimalarial action., 26 (19): [PMID:27544402] [10.1016/j.bmcl.2016.08.005] |
| 107. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 108. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 109. Kancharla P, Dodean RA, Li Y, Pou S, Pybus B, Melendez V, Read L, Bane CE, Vesely B, Kreishman-Deitrick M, Black C, Li Q, Sciotti RJ, Olmeda R, Luong TL, Gaona H, Potter B, Sousa J, Marcsisin S, Caridha D, Xie L, Vuong C, Zeng Q, Zhang J, Zhang P, Lin H, Butler K, Roncal N, Gaynor-Ohnstad L, Leed SE, Nolan C, Ceja FG, Rasmussen SA, Tumwebaze PK, Rosenthal PJ, Mu J, Bayles BR, Cooper RA, Reynolds KA, Smilkstein MJ, Riscoe MK, Kelly JX.. (2020) Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials., 63 (11): [PMID:32390431] [10.1021/acs.jmedchem.0c00539] |
| 110. Zuo Z, Liu X, Qian X, Zeng T, Sang N, Liu H, Zhou Y, Tao L, Zhou X, Su N, Yu Y, Chen Q, Luo Y, Zhao Y.. (2020) Bifunctional Naphtho[2,3-d][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production., 63 (14): [PMID:32496056] [10.1021/acs.jmedchem.0c00512] |
| 111. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 112. Eagon S,Hammill JT,Sigal M,Ahn KJ,Tryhorn JE,Koch G,Belanger B,Chaplan CA,Loop L,Kashtanova AS,Yniguez K,Lazaro H,Wilkinson SP,Rice AL,Falade MO,Takahashi R,Kim K,Cheung A,DiBernardo C,Kimball JJ,Winzeler EA,Eribez K,Mittal N,Gamo FJ,Crespo B,Churchyard A,García-Barbazán I,Baum J,Anderson MO,Laleu B,Guy RK. (2020) Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-b]pyridines., 63 (20.0): [PMID:32945666] [10.1021/acs.jmedchem.0c01152] |
| 113. Huang G,Murillo Solano C,Melendez J,Shaw J,Collins J,Banks R,Arshadi AK,Boonhok R,Min H,Miao J,Chakrabarti D,Yuan Y. (2020) Synthesis, Structure-Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines., 63 (20.0): [PMID:32959656] [10.1021/acs.jmedchem.0c00858] |
| 114. Tibon NS,Ng CH,Cheong SL. (2020) Current progress in antimalarial pharmacotherapy and multi-target drug discovery., 188 [PMID:31911292] [10.1016/j.ejmech.2019.111983] |
| 115. Huang G,Solano CM,Melendez J,Yu-Alfonzo S,Boonhok R,Min H,Miao J,Chakrabarti D,Yuan Y. (2021) Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions., 209 [PMID:33045660] [10.1016/j.ejmech.2020.112889] |
| 116. Ouji M,Nguyen M,Mustière R,Jimenez T,Augereau JM,Benoit-Vical F,Deraeve C. (2021) Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites., 39 [PMID:33636304] [10.1016/j.bmcl.2021.127884] |
| 117. Xu Y,Xue D,Bankhead A,Neamati N. (2020) Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?, 63 (23.0): [PMID:33103432] [10.1021/acs.jmedchem.0c01013] |
| 118. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 119. Iwasaki A, Ohtomo K, Kurisawa N, Shiota I, Rahmawati Y, Jeelani G, Nozaki T, Suenaga K.. (2021) Isolation, Structure Determination, and Total Synthesis of Hoshinoamide C, an Antiparasitic Lipopeptide from the Marine Cyanobacterium Caldora penicillata., 84 (1.0): [PMID:33369420] [10.1021/acs.jnatprod.0c01209] |
| 120. Amrane D, Primas N, Arnold CS, Hutter S, Louis B, Sanz-Serrano J, Azqueta A, Amanzougaghene N, Tajeri S, Mazier D, Verhaeghe P, Azas N, Botté C, Vanelle P.. (2021) Antiplasmodial 2-thiophenoxy-3-trichloromethyl quinoxalines target the apicoplast of Plasmodium falciparum., 224 [PMID:34364164] [10.1016/j.ejmech.2021.113722] |
| 121. Laleu B, Akao Y, Ochida A, Duffy S, Lucantoni L, Shackleford DM, Chen G, Katneni K, Chiu FCK, White KL, Chen X, Sturm A, Dechering KJ, Crespo B, Sanz LM, Wang B, Wittlin S, Charman SA, Avery VM, Cho N, Kamaura M.. (2021) Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials., 64 (17.0): [PMID:34437804] [10.1021/acs.jmedchem.1c00441] |
| 122. Monastyrskyi A, Brockmeyer F, LaCrue AN, Zhao Y, Maher SP, Maignan JR, Padin-Irizarry V, Sakhno YI, Parvatkar PT, Asakawa AH, Huang L, Casandra D, Mashkouri S, Kyle DE, Manetsch R.. (2021) Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1H)-Quinolones with Single Dose Cures., 64 (10.0): [PMID:33979164] [10.1021/acs.jmedchem.0c01104] |
| 123. Kancharla P, Li Y, Yeluguri M, Dodean RA, Reynolds KA, Kelly JX.. (2021) Total Synthesis and Antimalarial Activity of 2-(p-Hydroxybenzyl)-prodigiosins, Isoheptylprodigiosin, and Geometric Isomers of Tambjamine MYP1 Isolated from Marine Bacteria., 64 (12.0): [PMID:34111350] [10.1021/acs.jmedchem.1c00748] |
| 124. Martins-Duarte ES, Portes JA, da Silva RB, Pires HS, Garden SJ, de Souza W.. (2021) In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii., 50 [PMID:34666274] [10.1016/j.bmc.2021.116467] |
| 125. Patel OPS, Beteck RM, Legoabe LJ.. (2021) Antimalarial application of quinones: A recent update., 210 [PMID:33333397] [10.1016/j.ejmech.2020.113084] |
| 126. Zattoni IF, Delabio LC, Dutra JP, Kita DH, Scheiffer G, Hembecker M, Pereira GDS, Moure VR, Valdameri G.. (2022) Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators., 237 [PMID:35483322] [10.1016/j.ejmech.2022.114346] |
| 127. Lawong A, Gahalawat S, Okombo J, Striepen J, Yeo T, Mok S, Deni I, Bridgford JL, Niederstrasser H, Zhou A, Posner B, Wittlin S, Gamo FJ, Crespo B, Churchyard A, Baum J, Mittal N, Winzeler E, Laleu B, Palmer MJ, Charman SA, Fidock DA, Ready JM, Phillips MA.. (2021) Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum., 64 (5.0): [PMID:33620219] [10.1021/acs.jmedchem.0c02022] |
| 128. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X.. (2021) Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations., 64 (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569] |
| 129. Fan YL, Cheng XW, Wu JB, Liu M, Zhang FZ, Xu Z, Feng LS.. (2018) Antiplasmodial and antimalarial activities of quinolone derivatives: An overview., 146 [PMID:29360043] [10.1016/j.ejmech.2018.01.039] |
| 130. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
